Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Non-cash Items (2020 - 2025)

Treace Medical Concepts' Non-cash Items history spans 6 years, with the latest figure at $6.1 million for Q4 2025.

  • For Q4 2025, Non-cash Items fell 37.64% year-over-year to $6.1 million; the TTM value through Dec 2025 reached $6.1 million, down 37.64%, while the annual FY2025 figure was $6.1 million, 37.64% down from the prior year.
  • Non-cash Items reached $6.1 million in Q4 2025 per TMCI's latest filing, down from $9.8 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $12.8 million in Q4 2022 to a low of $3.7 million in Q4 2021.
  • Average Non-cash Items over 5 years is $7.9 million, with a median of $8.3 million recorded in 2021.
  • Peak YoY movement for Non-cash Items: surged 243.38% in 2022, then crashed 64.12% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $3.7 million in 2021, then soared by 243.38% to $12.8 million in 2022, then plummeted by 64.12% to $4.6 million in 2023, then skyrocketed by 113.38% to $9.8 million in 2024, then plummeted by 37.64% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Non-cash Items are $6.1 million (Q4 2025), $9.8 million (Q4 2024), and $4.6 million (Q4 2023).